Cell Impact Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Cell Impact has a total shareholder equity of SEK259.0M and total debt of SEK19.7M, which brings its debt-to-equity ratio to 7.6%. Its total assets and total liabilities are SEK315.0M and SEK56.0M respectively.
Belangrijke informatie
7.6%
Verhouding schuld/eigen vermogen
SEK 19.73m
Schuld
| Rente dekkingsratio | n/a |
| Contant | SEK 22.62m |
| Aandelen | SEK 259.01m |
| Totaal verplichtingen | SEK 56.00m |
| Totaal activa | SEK 315.01m |
Recente financiële gezondheidsupdates
Health Check: How Prudently Does Cell Impact (STO:CI) Use Debt?
May 13
Is Cell Impact (STO:CI) Using Debt In A Risky Way?
Jan 14Here's Why We're Not Too Worried About Cell Impact's (STO:CI B) Cash Burn Situation
May 09Recent updates
Health Check: How Prudently Does Cell Impact (STO:CI) Use Debt?
May 13Is Cell Impact (STO:CI) Using Debt In A Risky Way?
Jan 14Here's Why We're Not Too Worried About Cell Impact's (STO:CI B) Cash Burn Situation
May 09Investors Who Bought Cell Impact (STO:CI B) Shares Three Years Ago Are Now Up 428%
Feb 21
How Much Is Cell Impact AB (publ) (STO:CI B) Paying Its CEO?
Dec 27Analyse van de financiële positie
Kortlopende schulden: CI's short term assets (SEK97.2M) exceed its short term liabilities (SEK28.2M).
Langlopende schulden: CI's short term assets (SEK97.2M) exceed its long term liabilities (SEK27.8M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: CI has more cash than its total debt.
Schuld verminderen: CI's debt to equity ratio has increased from 2.1% to 7.6% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: CI has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: CI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.3% each year